Answer
Yes, Lemtrada (alemtuzumab) is contraindicated in patients taking antiplatelet or anticoagulant therapy.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked